scholarly journals Sphingosine-1-phosphate receptors regulate individual cell behaviours underlying the directed migration of prechordal plate progenitor cells during zebrafish gastrulation

Development ◽  
2008 ◽  
Vol 135 (18) ◽  
pp. 3043-3051 ◽  
Author(s):  
M. Kai ◽  
C.-P. Heisenberg ◽  
M. Tada

2008 ◽  
Vol 14 (2) ◽  
pp. 287-297 ◽  
Author(s):  
Kelly A. Smith ◽  
Sonja Chocron ◽  
Sophia von der Hardt ◽  
Emma de Pater ◽  
Alexander Soufan ◽  
...  


Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 2681-2681 ◽  
Author(s):  
Gabriele Seitz ◽  
Andreas M. Boehmler ◽  
Tina Wiesner ◽  
Lothar Kanz ◽  
Robert Möhle

Abstract Trafficking of hematopoietic stem and progenitor cells (HPC) is controlled by G protein coupled receptors (GPRs), particularly by the chemokine receptor CXCR4. However, homing of HPC does not exclusively depend on CXCR4 and its ligand SDF-1. In addition to chemokine receptors, also GPRs for non-peptide lipid mediators may be involved in HPC migration. In the present study, we demonstrate that sphingosine 1-phosphate (S1P) is chemotactic for human CD34+ HPC (optimum dose 5 μM), as measured in a modified Boyden chamber system. In CD34+ cell lines, the chemotactic response was even stronger and occurred at lower S1P concentrations (e.g., optimum dose 100 nM for Jurkat cells, 2-fold stronger migration compared to HPC). By RT-PCR, we measured mRNA expression of the 5 different S1P receptors (S1P1,2,3,4,5). All CD34+ hematopoietic cell lines analyzed (KG1, KG1a, Jurkat) expressed S1P1, a S1P receptor with known chemotactic activity, while CD34- cell lines (HL-60, THP-1) were negative for S1P1. In HL-60 cells, chemotaxis in response to S1P was even reduced compared to spontaneous migration, which might be due to the expression of S1P receptors other than S1P1 with known inhibitory effects, particularly S1P2. In mobilized peripheral blood CD34+ progenitor cells from different donors, S1P1 was consistently expressed in both CD34+CD38+ and more primitive CD34+CD38- HPC, while expression of S1P2,3,4,5 was variable. S1P induced also other typical responses of GPR-mediated signaling in CD34+ cell lines and HPC, such as polymerization of filamentous actin, as measured by flow cytometry after labeling of the cells with FITC-phalloidin. We conclude that S1P is a chemotactic factor for CD34+ HPC and CD34+ cell lines due to expression of the GPR S1P1. As megakaryocytes and platelets represent an abundant source of S1P in the bone marrow, our results suggest that S1P and its receptor S1P1 may contribute to trafficking and spatial distribution of HPC in the hematopoietic microenvironment.



Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 217-217
Author(s):  
Karin Golan ◽  
Aya Ludin ◽  
Tomer Itkin ◽  
Shiri Cohen-Gur ◽  
Orit Kollet ◽  
...  

Abstract Hematopoietic stem and progenitor cells (HSPC) are mostly retained in a quiescent, non-motile mode in the bone marrow (BM), shifting to a cycling, differentiating and migratory state on demand. How HSC replenish the blood with new mature leukocytes on a daily basis while maintaining a constant pool of primitive cells in the BM throughout life is not clear. Recently, we reported that the bioactive lipid Sphingosine 1-Phosphate (S1P) regulates HSPC mobilization via ROS signaling and CXCL12 secretion (Golan et al, Blood 2012). We hypothesize that S1P influences the daily circadian egress of HSPC and their proliferation. We report that S1P levels in the blood are increased following initiation of light at the peak of HSPC egress and are reduced towards the termination of light when circulating HSPC reach a nadir. Interestingly, mice with constitutively low S1P plasma levels due to lack of one of the enzymes that generates S1P (Sphingosine kinase 1), do not exhibit fluctuations of HSPC levels in the blood between day and night. We report that HSPC numbers in the BM are also regulated in a circadian manner. Unexpectedly, we found two different daily peaks: one in the morning, following initiation of light, which is accompanied by increased HSPC egress and the other at night after darkness, which is associated with reduced HSPC egress. In both peaks HSPC begin to cycle and differentiate via up-regulation of reactive oxygen species (ROS) however, the night peak had lower ROS levels. Concomitant with the peak of primitive stem and progenitor cells, we also observed (to a larger extent in the night peak), expansion of a rare activated macrophage/monocyte αSMA/Mac-1 population. This population maintains HSPC in a primitive state via COX2/PGE2 signaling that reduces ROS levels and increases BM stromal CXCL12 surface expression (Ludin et al, Nat. Imm. 2012). We identified two different BM peaks in HSPC levels that are regulated by the nervous system via circadian changes in ROS levels. Augmented ROS levels induce HSPC proliferation, differentiation and motility, which take place in the morning peak; however, they need to be restored to normal levels in order to prevent BM HSPC exhaustion. In the night peak, HSPC proliferate with less differentiation and egress, and activated macrophage/monocyte αSMA/Mac-1 cells are increased to restore ROS levels and activate CXCL12/CXCR4 interactions to maintain a HSPC primitive phenotype. Additionally, S1P also regulates HSPC proliferation, thus mice with low S1P levels share reduced hematopoietic progenitor cells in the BM. Interestingly S1P is required more for the HSPC night peak since in mice with low S1P levels, HSPC peak normally during day time but not at darkness. We suggest that the first peak is initiated via elevation of ROS by norepinephrine that is augmented in the BM following light-driven cues from the brain (Mendez-Ferrer at al, Nature 2008). The morning elevated ROS signal induces a decrease in BM CXCL12 levels and up-regulated MMP-9 activity, leading to HSC proliferation, as well as their detachment from their BM microenvironment, resulting in enhanced egress. Importantly, ROS inhibition by N-acetyl cysteine (NAC) reduced the morning HSPC peak. Since norepinephrine is an inhibitor of TNFα, upon light termination norepinephrine levels decrease and TNFα levels are up-regulated. TNFα induces activation of S1P in the BM, leading to the darkness peak in HSPC levels. S1P was previously shown also to induce PGE2 signaling, essential for HSPC maintenance by the rare activated αSMA/Mac-1 population. Indeed, in mice with low S1P levels, we could not detect a peak in COX2 levels in these BM cells during darkness. We conclude that S1P not only induces HSPC proliferation via augmentation of ROS levels, but also activates PGE2/COX2 signaling in αSMA/Mac-1 population to restore ROS levels and prevent HSPC differentiation and egress during the night peak. We hypothesize that the morning HSPC peak, involves proliferation, differentiation and egress, to allow HSPC to replenish the blood circulation with new cells. In contrast, the second HSPC night peak induces proliferation with reduced differentiation and egress, allowing the renewal of the BM HSPC pool. In summary, we identified two daily circadian peaks in HSPC BM levels that are regulated via light/dark cues and concomitantly allow HSPC replenishment of the blood and immune system, as well as maintenance of the HSPC constant pool in the BM. Disclosures: No relevant conflicts of interest to declare.



2015 ◽  
Vol 185 (10) ◽  
pp. 2819-2832 ◽  
Author(s):  
Caroline A. Blanc ◽  
Jonathan J. Grist ◽  
Hugh Rosen ◽  
Ilse Sears-Kraxberger ◽  
Oswald Steward ◽  
...  


2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Kasia Mierzejewska ◽  
Yuri M. Klyachkin ◽  
Janina Ratajczak ◽  
Ahmed Abdel-Latif ◽  
Magda Kucia ◽  
...  

Sphingosine-1-phosphate (S1P) is a crucial chemotactic factor in peripheral blood (PB) involved in the mobilization process and egress of hematopoietic stem/progenitor cells (HSPCs) from bone marrow (BM). Since S1P is present at high levels in erythrocytes, one might assume that, by increasing the plasma S1P level, the hemolysis of red blood cells would induce mobilization of HSPCs. To test this assumption, we induced hemolysis in mice by employing phenylhydrazine (PHZ). We observed that doubling the S1P level in PB from damaged erythrocytes induced only a marginally increased level of mobilization. However, if mice were exposed to PHZ together with the CXCR4 blocking agent, AMD3100, a robust synergistic increase in the number of mobilized HSPCs occurred. We conclude that hemolysis, even if it significantly elevates the S1P level in PB, also requires attenuation of the CXCR4-SDF-1 axis-mediated retention in BM niches for HSPC mobilization to occur. Our data also further confirm that S1P is a major chemottractant present in plasma and chemoattracts HSPCs into PB under steady-state conditions. However, to egress from BM, HSPCs first have to be released from BM niches by blocking the SDF-1-CXCR4 retention signal.



Stroke ◽  
2008 ◽  
Vol 39 (12) ◽  
pp. 3411-3417 ◽  
Author(s):  
Atsushi Kimura ◽  
Tsukasa Ohmori ◽  
Yuji Kashiwakura ◽  
Ryunosuke Ohkawa ◽  
Seiji Madoiwa ◽  
...  


PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0123437 ◽  
Author(s):  
Priscilla A. Williams ◽  
Roberta S. Stilhano ◽  
Vivian P. To ◽  
Lyndon Tran ◽  
Kevin Wong ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document